Of note, many of these activated pathways can now be imaged noninvasively using molecular imaging techniques [ 7, 8, 12, 15, 25].
PET and SPECT are molecular imaging techniques that use radiolabeled molecules to image gene expression in vivo.
Now, his intellectual descendents are using information from the human genome project and similar efforts to develop molecular imaging techniques that could probe each bodily cell -- and spot diseases before any symptoms occur.
New molecular imaging techniques permit assessments of the target before, during, and after treatment.
These molecular imaging techniques can lead to enhanced, individualised clinical management of diseased patients at an early stage.
Functional and molecular imaging techniques in clinical practice may allow the assessment of tumour-specific characteristics and tumour heterogeneity.
Clearly, novel macroscopic and molecular imaging techniques will form the cornerstone of personalised diagnosis in the near future.
Noninvasive molecular imaging techniques such as PET/CT can be used to probe the microenvironment of tumors in vivo.
The expression or activity of specific enzymes including proteases can be monitored by cutting edge molecular imaging techniques.
Numerous studies have demonstrated that molecular imaging techniques play a central role in the era of personalized medicine.
Cellular and molecular imaging techniques can be used non-invasively, quantitatively and repetitively to visualize cell populations in vivo [24].
